A detailed history of Joel Isaacson & Co., LLC transactions in Insulet Corp stock. As of the latest transaction made, Joel Isaacson & Co., LLC holds 861 shares of PODD stock, worth $226,641. This represents 0.01% of its overall portfolio holdings.

Number of Shares
861
Holding current value
$226,641
% of portfolio
0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$180.69 - $239.01 $155,574 - $205,787
861 New
861 $200,000
Q1 2023

Apr 24, 2023

SELL
$276.36 - $326.03 $27,636 - $32,602
-100 Reduced 10.41%
861 $274,000
Q4 2022

Jan 27, 2023

BUY
$212.22 - $313.46 $203,943 - $301,235
961 New
961 $0

Others Institutions Holding PODD

About INSULET CORP


  • Ticker PODD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 69,403,600
  • Market Cap $18.3B
  • Description
  • Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...
More about PODD
Track This Portfolio

Track Joel Isaacson & Co., LLC Portfolio

Follow Joel Isaacson & Co., LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Joel Isaacson & Co., LLC, based on Form 13F filings with the SEC.

News

Stay updated on Joel Isaacson & Co., LLC with notifications on news.